LYNCO CLINICAL: what changed
LYNCO CLINICAL
Largest movements
- Tangible fixed assets +€264,409
up €264,409 (+481%), from €54,984 to €319,392
of which Land and buildings: +€237,552
- Cash -€40,155
down €40,155 (-49.7%), from €80,807 to €40,652
mainly Investment in fixed assets (net) (-€303,447)
- Receivables within one year -€21,119
down €21,119 (-48.7%), from €43,361 to €22,242
- Debts after one year +€138,255
up €138,255 (+983%), from €14,069 to €152,323
- Reserves +€29,993
up €29,993 (+21.0%), from €142,509 to €172,502
- Current portion of long-term debt +€22,891
up €22,891 (+289%), from €7,927 to €30,818
- Short-term financial debts +€6,247
new in 2025: €6,247
- Depreciation +€14,299
up €14,299 (+57.8%), from €24,739 to €39,038
- Taxes -€7,745
down €7,745 (-45.6%), from €16,980 to €9,235
- Financial charges +€7,186
up €7,186 (+397%), from €1,811 to €8,997
of which Financial charges: +€6,583
- Gross operating margin +€4,634
up €4,634 (+5.4%), from €86,394 to €91,028
- Staff costs +€2,223
up €2,223, from €0 to €2,223
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €186,274 | €388,114 | +€201,840 | +108% |
| Fixed assets | 21/28 | €54,984 | €319,392 | +€264,409 | +481% |
| Intangible fixed assets | 21 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €54,984 | €319,392 | +€264,409 | +481% |
| Land and buildings | 22 | €18,956 | €256,508 | +€237,552 | +1,253% |
| Plant, machinery and equipment | 23 | €33,306 | €59,616 | +€26,309 | +79.0% |
| Furniture and vehicles | 24 | €2,722 | €3,269 | +€548 | +20.1% |
| Current assets | 29/58 | €131,290 | €68,721 | -€62,569 | -47.7% |
| Stocks and contracts in progress | 3 | €5,356 | €5,081 | -€275 | -5.1% |
| Stocks | 30/36 | €5,356 | €5,081 | -€275 | -5.1% |
| Amounts receivable within one year | 40/41 | €43,361 | €22,242 | -€21,119 | -48.7% |
| Trade receivables | 40 | €43,361 | €22,242 | -€21,119 | -48.7% |
| Cash at bank and in hand | 54/58 | €80,807 | €40,652 | -€40,155 | -49.7% |
| Deferred charges and accrued income | 490/1 | €1,766 | €747 | -€1,020 | -57.7% |
| Total equity and liabilities | 10/49 | €186,274 | €388,114 | +€201,840 | +108% |
| Equity | 10/15 | €140,446 | €170,439 | +€29,993 | +21.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €142,509 | €172,502 | +€29,993 | +21.0% |
| Distributable reserves | 133 | €142,509 | €172,502 | +€29,993 | +21.0% |
| Profit (loss) carried forward | 14 | -€20,663 | -€20,663 | = | 0.0% |
| Amounts payable | 17/49 | €45,828 | €217,675 | +€171,847 | +375% |
| Amounts payable after more than one year | 17 | €14,069 | €152,323 | +€138,255 | +983% |
| Financial debts | 170/4 | €14,069 | €152,323 | +€138,255 | +983% |
| Amounts payable within one year | 42/48 | €31,725 | €65,352 | +€33,626 | +106% |
| Current portion of amounts payable after more than one year | 42 | €7,927 | €30,818 | +€22,891 | +289% |
| Financial debts | 43 | - | €6,247 | +€6,247 | |
| Credit institutions | 430/8 | - | €6,247 | +€6,247 | |
| Trade debts | 44 | €1,935 | €2,549 | +€614 | +31.8% |
| Suppliers | 440/4 | €1,935 | €2,549 | +€614 | +31.8% |
| Taxes, remuneration and social security | 45 | €21,447 | €24,265 | +€2,818 | +13.1% |
| Taxes | 450/3 | €21,447 | €24,265 | +€2,818 | +13.1% |
| Other amounts payable | 47/48 | €417 | €1,473 | +€1,056 | +253% |
| Accrued charges and deferred income | 492/3 | €34 | €0 | -€34 | -100% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €0 | €2,223 | +€2,223 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,739 | €39,038 | +€14,299 | +57.8% |
| Other operating charges | 640/8 | €513 | €1,802 | +€1,289 | +251% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €86,394 | €91,028 | +€4,634 | +5.4% |
| Operating profit (loss) | 9901 | €61,142 | €47,964 | -€13,178 | -21.6% |
| Financial income | 75/76B | €153 | €260 | +€107 | +70.0% |
| Recurring financial income | 75 | €153 | €260 | +€107 | +70.0% |
| Financial charges | 65/66B | €1,811 | €8,997 | +€7,186 | +397% |
| Recurring financial charges | 65 | €1,811 | €8,394 | +€6,583 | +363% |
| Non-recurring financial charges | 66B | - | €603 | +€603 | |
| Profit (loss) for the period before taxes | 9903 | €59,484 | €39,228 | -€20,256 | -34.1% |
| Income taxes | 67/77 | €16,980 | €9,235 | -€7,745 | -45.6% |
| Profit (loss) for the period | 9904 | €42,504 | €29,993 | -€12,510 | -29.4% |
| Profit (loss) for the period to be appropriated | 9905 | €42,504 | €29,993 | -€12,510 | -29.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.